On February 11, 2026, Pulse Biological Sciences (PLSE) disclosed six insider trading transactions. Executive Danahy Kevin Patrick sold 20,000 shares on February 10, 2026.
[Recent Insider Transactions]
Disclosure Date
Position
Name
Transaction Date
Buy/Sell
Quantity
Price per Share (USD)
Total Amount (USD)
February 11, 2026
Executive
Danahy Kevin Patrick
February 10, 2026
Sell
20,000
23.52
472,000
February 11, 2026
Executive
Danahy Kevin Patrick
February 11, 2026
Sell
20,000
25.20
504,000
February 11, 2026
Executive
Danahy Kevin Patrick
February 11, 2026
Buy
60,000
1.53
91,800
February 11, 2026
Executive
Danahy Kevin Patrick
February 9, 2026
Sell
20,000
21.45
429,000
October 7, 2025
Executive
Danahy Kevin Patrick
October 2, 2025
Buy
4,600
1.53
7,038
October 7, 2025
Executive
Danahy Kevin Patrick
October 2, 2025
Sell
4,600
18.53
85,038
September 22, 2025
Executive
Danahy Kevin Patrick
September 19, 2025
Buy
20,400
1.53
31,212
September 22, 2025
Executive
Danahy Kevin Patrick
September 19, 2025
Sell
400
18.48
7,392
September 22, 2025
Executive
Danahy Kevin Patrick
September 18, 2025
Sell
20,000
18.49
369,800
September 18, 2025
Director
UECKER DARRIN
September 16, 2025
Sell
25,000
16.28
407,000
[Company Information]
Pulse Biological Sciences, Inc., registered as Electroblate, Inc. on May 19, 2014, in Nevada, is a medical device company developing a new proprietary platform technology, nanosecond pulsed electrical signals (NPES), for biomedical applications. Electroblate, Inc. was renamed Pulse Biological Sciences, effective December 8, 2015.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
US Stock Insider Trading | Pulse Biosciences Discloses 6 Insider Transactions on February 11
On February 11, 2026, Pulse Biological Sciences (PLSE) disclosed six insider trading transactions. Executive Danahy Kevin Patrick sold 20,000 shares on February 10, 2026.
[Recent Insider Transactions]
[Company Information]
Pulse Biological Sciences, Inc., registered as Electroblate, Inc. on May 19, 2014, in Nevada, is a medical device company developing a new proprietary platform technology, nanosecond pulsed electrical signals (NPES), for biomedical applications. Electroblate, Inc. was renamed Pulse Biological Sciences, effective December 8, 2015.